Da Avastin kan påvirke sårheling negativt, blev patienter som havde fået foretaget større operationer indenfor de sidste 28 dage, ekskluderet fra deltagelse i kliniske studier i fase III.
As Avastin may adversely impact wound healing, patients who had major surgery within the last 28 days were excluded from participation in phase III clinical trials.